CSafe has joined Pharma.Aero, reinforcing the organisation’s collaborative network with extensive expertise in temperature-controlled shipping solutions for the pharmaceutical and life sciences industry.
With active and passive cold chain solutions supporting bulk air cargo, parcel, and cell and gene therapy applications, CSafe serves pharmaceutical manufacturers, freight forwarders, and airlines across more than 185 countries. The company’s addition further expands Pharma.Aero’s ecosystem of stakeholders working together to strengthen resilient, efficient, and patient-centric healthcare supply chains.
Founded in 1979 and headquartered in Monroe, Ohio, USA, CSafe operates more than 75 service locations worldwide. Its temperature-controlled shipping solutions have supported the delivery of more than 10 billion doses, helping life-enhancing therapies reach patients around the globe.
We’re glad to join Pharma.Aero and work alongside the airlines, freight forwarders, and manufacturers helping shape where pharma logistics goes next. For CSafe, that means contributing directly to the projects and standards this group is building. We’re looking forward to bringing our cold chain experience to that work and helping raise the bar for how our industry operates.
Dharmesh Chauhan, Sr Vice President – Global Sales, CSafe
By joining Pharma.Aero, CSafe becomes part of a global network of manufacturers, airlines, airports, logistics providers, technology companies, and academic institutions working collaboratively to advance innovation, education, and operational excellence across Life Science and MedTech logistics.
